Voyager Therapeutics (STU:VT6) Dividends Received


STU:VT6 Voyager Therapeutics Inc STU:VT6
46 GF Score
Price €3.02
GF Value €1.44
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Voyager Therapeutics Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

STU:VT6
46GF Score
Voyager Therapeutics Inc STU:VT6
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Voyager Therapeutics (STU:VT6) Overvalued in 2026?

Based on GuruFocus' analysis, Voyager Therapeutics stock appears to be overvalued. The current stock price of €3.02 is trading 109.6% above its estimated GF Value™ of €1.44. GuruFocus considers Voyager Therapeutics to be Significantly Overvalued.

Key valuation signals for STU:VT6:

  • Dividends Received:
  • GF Value™: €1.44 vs. price of €3.02 (109.6% above fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the STU:VT6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Voyager Therapeutics Business Description

Address 75 Hayden Avenue, Lexington, MA, USA, 02421
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
46GF Score

Get the complete analysis for STU:VT6

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.02
Price
€1.44
GF Value